Date authorised
1 April 2013
Companies House
03302887
Last scraped
2 weeks ago
Watch for changes

Addresses

The contact details this firm has registered with the FCA.

  • Principal Place of Business

    8 Bishopsgate
    London
    EC2N 4BQ
    UNITED KINGDOM
    Phone
    +4402072208500
  • Complaints Contact

    8 Bishopsgate
    London
    EC2N 4BQ
    UNITED KINGDOM
    Phone
    +4402072208500

What this firm is allowed to do

The regulated activities the FCA has granted this firm permission to carry out.

  • Authorised to Operate

    Show 1 limitation
    • · The firm can only agree to carry on the regulated activities specified in this Notice.
  • Arranges Investments

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Insurance Admin

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Stockbroking

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

  • Investment Setup

    For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts

Approved individuals

Senior staff personally approved by the FCA to hold their roles here.

  • Alexander Kasparian

    IRN AXK87164

    • SMF17 Money Laundering Reporting Officer (MLRO) (since 1 Sep 2025)
    • SMF16 Compliance Oversight (since 1 Sep 2025)
  • Alexandra Jayne Moon

    IRN AXM05623

    • SMF18 Other Overall Responsibility (since 28 Aug 2025)
  • Andrew Robert Holmes

    IRN ARH01108

    • [FCA CF] Significant management (since 20 Nov 2025)
    • SMF1 Chief Executive (26 Mar 2024 to 25 Nov 2024)
    • Responsible for Insurance Distribution (26 Mar 2024 to 25 Nov 2024)
    • SMF3 Executive Director (9 Dec 2019 to 21 Jan 2025)
    • CF29 Significant management (1 Nov 2007 to 19 Jun 2012)
    • CF17 Significant Mgt (Other Business Operations) (14 Jan 2005 to 31 Oct 2007)
    • CF1 Director (14 Jan 2005 to 8 Dec 2019)
  • Angus Marshall

    IRN AXM05232

    • [FCA CF] Significant management (since 30 Apr 2021)
  • Barbara Bader-Klein

    IRN BXB00102

    • [FCA CF] Significant management (23 Jul 2024 to 16 May 2025)
  • Bryan Ruthven Patrick Joseph

    IRN BRJ01015

    • SMF10 Chair of the Risk Committee (since 16 Sep 2024)
  • Christopher Browne

    IRN CXB01121

    • [FCA CF] Significant management (since 16 Sep 2025)
  • Clarissa Amelia Isherwood

    IRN CAI01010

    • CF1 Director (14 Jan 2005 to 1 Dec 2005)
  • Daniel Trueman

    IRN DXT01413

    • SMF3 Executive Director (25 Mar 2024 to 28 Feb 2025)
  • David Alan Whileman

    IRN DAW01120

    • CF2 Non Executive Director (26 Feb 2010 to 19 Jun 2012)

Appointed representatives

Smaller firms operating under this firm's FCA authorisation.

Recent activity

Updates to this firm's record on the FCA register.

No changes recorded yet.